Glucose-insulin-potassium infusion


 * GIK

Overview
GIK is a pharmacologic regimen that has been extensively studied as adjunctive therapy in STEMI patients to reduce reperfusion injury. The majority of recent trials do not demonstrate a benefit on clinical outcomes.